Risk adjusted net present value: What is the current valuation of Vertex Pharmaceuticals’s Suzetrigine?
The revenue for Suzetrigine is expected to reach an annual total of $946 mn by 2040 globally based off GlobalData’s Revenue Model. The drug’s revenue forecasts along with estimated costs are used to measure the value of an investment opportunity in that …